Monoclonal antibody therapies will be the first drugs permitted to take advantage of alternatives, including advanced lab simulations and artificial intelligence. A pilot framework to phase out the decades-long requirement for animal testing will be rolled out in the coming year, the FDA said.

Older heart failure patients with no immediate family are especially vulnerable. Additional interventions may be necessary to reach these patients and provide the best care possible.

The Department of Health and Human Services is looking to replace lab animals with AI models. Even more bullish on AI is the new boss at the Centers for Medicare and Medicaid Services. 

GenAI initiatives are complex and—in some cases—costly. “As such, the main rationale for pursuing them needs to be business growth, not workforce reductions.” 

The authors of the survey report note that AI tools mentioned by respondents run the gamut from automated appointment reminders to dynamic “care gap” messaging. 

Despite the prevalence of this concern, only 17% are screened for these health-related social challenges, experts write in JACR. 

A new study focuses on the role oxalic acid may play in the body’s ability to eliminate gadolinium after an MRI study.

Some AI decision-support models have a proclivity for recommending aggressive care pathways. And doing so on the basis of patient demographics, not medical necessity.